Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Imbruvica market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Imbruvica market. Detailed analysis of key players, along with key growth strategies adopted by Imbruvica industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
SP Laboratories
AbbVie (Pharmacyclics)
Johnson & Johnson (Janssen Biotech)
By Type:
5 mg
10 mg
140 mg
By End-User:
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Waldenström's Macroglobulinemia
Relapsed/Refractory Marginal Zone Lymphoma
Chronic Graft-Versus-Host-Disease
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Imbruvica Market
-
1.3 Market Segment by Type
-
1.3.1 China Imbruvica Market Size and Growth Rate of 5 mg from 2016 to 2027
-
1.3.2 China Imbruvica Market Size and Growth Rate of 10 mg from 2016 to 2027
-
1.3.3 China Imbruvica Market Size and Growth Rate of 140 mg from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Imbruvica Market Size and Growth Rate of Mantle Cell Lymphoma from 2016 to 2027
-
1.4.2 China Imbruvica Market Size and Growth Rate of Chronic Lymphocytic Leukemia from 2016 to 2027
-
1.4.3 China Imbruvica Market Size and Growth Rate of Waldenström's Macroglobulinemia from 2016 to 2027
-
1.4.4 China Imbruvica Market Size and Growth Rate of Relapsed/Refractory Marginal Zone Lymphoma from 2016 to 2027
-
1.4.5 China Imbruvica Market Size and Growth Rate of Chronic Graft-Versus-Host-Disease from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Imbruvica Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Imbruvica by Major Types
-
3.4.1 Market Size and Growth Rate of 5 mg
-
3.4.2 Market Size and Growth Rate of 10 mg
-
3.4.3 Market Size and Growth Rate of 140 mg
4 Segmentation of Imbruvica Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Imbruvica by Major End-Users
-
4.4.1 Market Size and Growth Rate of Imbruvica in Mantle Cell Lymphoma
-
4.4.2 Market Size and Growth Rate of Imbruvica in Chronic Lymphocytic Leukemia
-
4.4.3 Market Size and Growth Rate of Imbruvica in Waldenström's Macroglobulinemia
-
4.4.4 Market Size and Growth Rate of Imbruvica in Relapsed/Refractory Marginal Zone Lymphoma
-
4.4.5 Market Size and Growth Rate of Imbruvica in Chronic Graft-Versus-Host-Disease
5 Market Analysis by Regions
-
5.1 China Imbruvica Production Analysis by Regions
-
5.2 China Imbruvica Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Imbruvica Landscape Analysis
-
6.1 North China Imbruvica Landscape Analysis by Major Types
-
6.2 North China Imbruvica Landscape Analysis by Major End-Users
7 Central China Imbruvica Landscape Analysis
-
7.1 Central China Imbruvica Landscape Analysis by Major Types
-
7.2 Central China Imbruvica Landscape Analysis by Major End-Users
8 South China Imbruvica Landscape Analysis
-
8.1 South China Imbruvica Landscape Analysis by Major Types
-
8.2 South China Imbruvica Landscape Analysis by Major End-Users
9 East China Imbruvica Landscape Analysis
-
9.1 East China Imbruvica Landscape Analysis by Major Types
-
9.2 East China Imbruvica Landscape Analysis by Major End-Users
10 Northeast China Imbruvica Landscape Analysis
-
10.1 Northeast China Imbruvica Landscape Analysis by Major Types
-
10.2 Northeast China Imbruvica Landscape Analysis by Major End-Users
11 Southwest China Imbruvica Landscape Analysis
-
11.1 Southwest China Imbruvica Landscape Analysis by Major Types
-
11.2 Southwest China Imbruvica Landscape Analysis by Major End-Users
12 Northwest China Imbruvica Landscape Analysis
-
12.1 Northwest China Imbruvica Landscape Analysis by Major Types
-
12.2 Northwest China Imbruvica Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 SP Laboratories
-
13.1.1 SP Laboratories Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 AbbVie (Pharmacyclics)
-
13.2.1 AbbVie (Pharmacyclics) Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Johnson & Johnson (Janssen Biotech)
-
13.3.1 Johnson & Johnson (Janssen Biotech) Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Imbruvica Market Size and Growth Rate of 5 mg from 2016 to 2027
-
Figure China Imbruvica Market Size and Growth Rate of 10 mg from 2016 to 2027
-
Figure China Imbruvica Market Size and Growth Rate of 140 mg from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Imbruvica Market Size and Growth Rate of Mantle Cell Lymphoma from 2016 to 2027
-
Figure China Imbruvica Market Size and Growth Rate of Chronic Lymphocytic Leukemia from 2016 to 2027
-
Figure China Imbruvica Market Size and Growth Rate of Waldenström's Macroglobulinemia from 2016 to 2027
-
Figure China Imbruvica Market Size and Growth Rate of Relapsed/Refractory Marginal Zone Lymphoma from 2016 to 2027
-
Figure China Imbruvica Market Size and Growth Rate of Chronic Graft-Versus-Host-Disease from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Imbruvica Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Imbruvica Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Imbruvica
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Imbruvica by Different Types from 2016 to 2027
-
Table Consumption Share of Imbruvica by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 5 mg
-
Figure Market Size and Growth Rate of 10 mg
-
Figure Market Size and Growth Rate of 140 mg
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Imbruvica by Different End-Users from 2016 to 2027
-
Table Consumption Share of Imbruvica by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Mantle Cell Lymphoma
-
Figure Market Size and Growth Rate of Chronic Lymphocytic Leukemia
-
Figure Market Size and Growth Rate of Waldenström's Macroglobulinemia
-
Figure Market Size and Growth Rate of Relapsed/Refractory Marginal Zone Lymphoma
-
Figure Market Size and Growth Rate of Chronic Graft-Versus-Host-Disease
-
Table China Imbruvica Production by Regions
-
Table China Imbruvica Production Share by Regions
-
Figure China Imbruvica Production Share by Regions in 2016
-
Figure China Imbruvica Production Share by Regions in 2021
-
Figure China Imbruvica Production Share by Regions in 2027
-
Table China Imbruvica Consumption by Regions
-
Table China Imbruvica Consumption Share by Regions
-
Figure China Imbruvica Consumption Share by Regions in 2016
-
Figure China Imbruvica Consumption Share by Regions in 2021
-
Figure China Imbruvica Consumption Share by Regions in 2027
-
Table North China Imbruvica Consumption by Types from 2016 to 2027
-
Table North China Imbruvica Consumption Share by Types from 2016 to 2027
-
Figure North China Imbruvica Consumption Share by Types in 2016
-
Figure North China Imbruvica Consumption Share by Types in 2021
-
Figure North China Imbruvica Consumption Share by Types in 2027
-
Table North China Imbruvica Consumption by End-Users from 2016 to 2027
-
Table North China Imbruvica Consumption Share by End-Users from 2016 to 2027
-
Figure North China Imbruvica Consumption Share by End-Users in 2016
-
Figure North China Imbruvica Consumption Share by End-Users in 2021
-
Figure North China Imbruvica Consumption Share by End-Users in 2027
-
Table Central China Imbruvica Consumption by Types from 2016 to 2027
-
Table Central China Imbruvica Consumption Share by Types from 2016 to 2027
-
Figure Central China Imbruvica Consumption Share by Types in 2016
-
Figure Central China Imbruvica Consumption Share by Types in 2021
-
Figure Central China Imbruvica Consumption Share by Types in 2027
-
Table Central China Imbruvica Consumption by End-Users from 2016 to 2027
-
Table Central China Imbruvica Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Imbruvica Consumption Share by End-Users in 2016
-
Figure Central China Imbruvica Consumption Share by End-Users in 2021
-
Figure Central China Imbruvica Consumption Share by End-Users in 2027
-
Table South China Imbruvica Consumption by Types from 2016 to 2027
-
Table South China Imbruvica Consumption Share by Types from 2016 to 2027
-
Figure South China Imbruvica Consumption Share by Types in 2016
-
Figure South China Imbruvica Consumption Share by Types in 2021
-
Figure South China Imbruvica Consumption Share by Types in 2027
-
Table South China Imbruvica Consumption by End-Users from 2016 to 2027
-
Table South China Imbruvica Consumption Share by End-Users from 2016 to 2027
-
Figure South China Imbruvica Consumption Share by End-Users in 2016
-
Figure South China Imbruvica Consumption Share by End-Users in 2021
-
Figure South China Imbruvica Consumption Share by End-Users in 2027
-
Table East China Imbruvica Consumption by Types from 2016 to 2027
-
Table East China Imbruvica Consumption Share by Types from 2016 to 2027
-
Figure East China Imbruvica Consumption Share by Types in 2016
-
Figure East China Imbruvica Consumption Share by Types in 2021
-
Figure East China Imbruvica Consumption Share by Types in 2027
-
Table East China Imbruvica Consumption by End-Users from 2016 to 2027
-
Table East China Imbruvica Consumption Share by End-Users from 2016 to 2027
-
Figure East China Imbruvica Consumption Share by End-Users in 2016
-
Figure East China Imbruvica Consumption Share by End-Users in 2021
-
Figure East China Imbruvica Consumption Share by End-Users in 2027
-
Table Northeast China Imbruvica Consumption by Types from 2016 to 2027
-
Table Northeast China Imbruvica Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Imbruvica Consumption Share by Types in 2016
-
Figure Northeast China Imbruvica Consumption Share by Types in 2021
-
Figure Northeast China Imbruvica Consumption Share by Types in 2027
-
Table Northeast China Imbruvica Consumption by End-Users from 2016 to 2027
-
Table Northeast China Imbruvica Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Imbruvica Consumption Share by End-Users in 2016
-
Figure Northeast China Imbruvica Consumption Share by End-Users in 2021
-
Figure Northeast China Imbruvica Consumption Share by End-Users in 2027
-
Table Southwest China Imbruvica Consumption by Types from 2016 to 2027
-
Table Southwest China Imbruvica Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Imbruvica Consumption Share by Types in 2016
-
Figure Southwest China Imbruvica Consumption Share by Types in 2021
-
Figure Southwest China Imbruvica Consumption Share by Types in 2027
-
Table Southwest China Imbruvica Consumption by End-Users from 2016 to 2027
-
Table Southwest China Imbruvica Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Imbruvica Consumption Share by End-Users in 2016
-
Figure Southwest China Imbruvica Consumption Share by End-Users in 2021
-
Figure Southwest China Imbruvica Consumption Share by End-Users in 2027
-
Table Northwest China Imbruvica Consumption by Types from 2016 to 2027
-
Table Northwest China Imbruvica Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Imbruvica Consumption Share by Types in 2016
-
Figure Northwest China Imbruvica Consumption Share by Types in 2021
-
Figure Northwest China Imbruvica Consumption Share by Types in 2027
-
Table Northwest China Imbruvica Consumption by End-Users from 2016 to 2027
-
Table Northwest China Imbruvica Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Imbruvica Consumption Share by End-Users in 2016
-
Figure Northwest China Imbruvica Consumption Share by End-Users in 2021
-
Figure Northwest China Imbruvica Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of SP Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SP Laboratories
-
Figure Sales and Growth Rate Analysis of SP Laboratories
-
Figure Revenue and Market Share Analysis of SP Laboratories
-
Table Product and Service Introduction of SP Laboratories
-
Table Company Profile and Development Status of AbbVie (Pharmacyclics)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie (Pharmacyclics)
-
Figure Sales and Growth Rate Analysis of AbbVie (Pharmacyclics)
-
Figure Revenue and Market Share Analysis of AbbVie (Pharmacyclics)
-
Table Product and Service Introduction of AbbVie (Pharmacyclics)
-
Table Company Profile and Development Status of Johnson & Johnson (Janssen Biotech)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson (Janssen Biotech)
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson (Janssen Biotech)
-
Figure Revenue and Market Share Analysis of Johnson & Johnson (Janssen Biotech)
-
Table Product and Service Introduction of Johnson & Johnson (Janssen Biotech)
-
